See the DrugPatentWatch profile for aspirin

Based on the available information, there is no one-size-fits-all answer to how long aspirin should be taken for heart disease. The use of aspirin for heart disease is a decision that should be made in consultation with a healthcare provider, taking into account the individual's medical history and current health status.

Aspirin is known to have blood-thinning properties, which can help prevent blood clots from forming and reduce the risk of heart attack and stroke. However, long-term use of aspirin can also increase the risk of bleeding and other side effects.

According to the American Heart Association, low-dose aspirin (75-100 milligrams) may be recommended for people with coronary artery disease, but the decision to start or stop taking aspirin should be based on a careful evaluation of the individual's overall health and risk factors.

A study published in the Journal of the American Medical Association found that for people who have had a heart attack or stroke, taking aspirin for at least two years can reduce the risk of another cardiovascular event. However, the study also noted that the benefits of long-term aspirin use may be outweighed by the risks for some people.

It is important to note that aspirin is just one part of an overall treatment plan for heart disease, which may also include lifestyle changes, other medications, and medical procedures.

In summary, the decision to take aspirin for heart disease should be made in consultation with a healthcare provider, taking into account the individual's medical history and current health status.

Sources:

* American Heart Association. (n.d.). Aspirin and Heart Disease, Stroke. Retrieved from <https://www.heart.org/en/health-topics/heart-attack/treatment-of-a-heart-attack/aspirin-and-heart-disease-stroke>.
* Fihn, S. D., Gardin, J. M., Abrams, J., Berry, J. D., Blumenthal, R. S., Carney, R. M., ... & Yeboah, J. (2014). 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 64(18), 1929-1949.
* DrugPatentWatch.com. (n.d.). Aspirin. Retrieved from <https://www.drugpatentwatch.com/drugs/aspirin>.